Valuation: IXICO plc

Market Cap 28.47M 37.82M 34.08M 31.49M 53.86M 3.55B 55.19M 377M 150M 1.9B 142M 139M 6.05B P/E 2026 *
-9.29x
P/E 2027 * -10x
Enterprise Value 18.27M 24.27M 21.87M 20.21M 34.56M 2.28B 35.41M 242M 96.52M 1.22B 91.07M 89.13M 3.88B EV / Sales 2026 *
2.28x
EV / Sales 2027 * 2.49x
Free-Float
89.57%
Yield 2026 *
-
Yield 2027 * -
1 week-16.13%
Current month+10.64%
1 month+67.74%
3 months+79.31%
6 months+96.23%
Current year+10.64%
1 week 12
Extreme 12
14.44
1 month 7
Extreme 7
17
Current year 6.26
Extreme 6.26
17
1 year 6.26
Extreme 6.26
17
3 years 6.26
Extreme 6.26
17
5 years 6.26
Extreme 6.26
68
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 2024-08-18
Director of Finance/CFO 50 2019-08-20
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 2019-08-20
Director/Board Member 60 2022-01-20
Date Insider Type Main position Quantity % Market Cap. Importance
7/15/26 Buy

Chairman

50,006 0.0228%
6/13/25 Free 350,000 0.3777%
6/13/25 Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-16.13%+20.93%-7.14% 37.82M
-1.06%-0.07%+60.76%+68.61% 67.53B
+1.30%+7.41%+14.79%+92.69% 60.74B
+0.39%+0.30%+20.04%+98.33% 55.66B
-0.95%+11.17%+22.21%+110.93% 47.97B
-0.23%+4.07%+25.63%+40.08% 45.24B
-6.40%-9.51%+181.99%+816.79% 39.08B
+1.97%+3.50%+25.78%+50.98% 35.34B
-0.56%-0.48%+85.57%+65.40% 33.45B
+1.05%+9.77%-37.66%+408.42% 26.49B
Average -0.45%-0.08%+42.00%+174.51% 41B
Weighted average by Cap. -0.48%+1.64%+44.30%+169.12%

Financials

2026 *2027 *
Net sales 8M 10.63M 9.58M 8.85M 15.14M 997M 15.51M 106M 42.27M 534M 39.89M 39.04M 1.7B 9M 11.96M 10.78M 9.96M 17.03M 1.12B 17.45M 119M 47.55M 601M 44.87M 43.92M 1.91B
Net income -2.1M -2.79M -2.51M -2.32M -3.97M -262M -4.07M -27.84M -11.1M -140M -10.47M -10.25M -446M -2.8M -3.72M -3.35M -3.1M -5.3M -349M -5.43M -37.12M -14.79M -187M -13.96M -13.66M -595M
Net Debt -10.2M -13.55M -12.21M -11.28M -19.3M -1.27B -19.77M -135M -53.9M -681M -50.85M -49.77M -2.17B -6.1M -8.1M -7.3M -6.75M -11.54M -760M -11.83M -80.87M -32.23M -407M -30.41M -29.77M -1.3B
Projected Income Statement - Annual - IXICO plc
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
26-11-12 GBX 13.00 0.00% 0
26-11-11 GBX 13.00 0.00% 100,960
26-11-10 GBX 13.00 0.00% 2,631
26-11-09 GBX 13.00 0.00% 48,573
26-11-06 GBX 13.00 -10.34% 313,419
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - IXICO plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1300GBP
Average target price
0.2600GBP
Spread / Average Target
+100.00%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - IXICO plc